Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression

Abstract

Dendritic cells (DC) are important antigen presenting cells (APC) and play a major role in initiating and orchestrating immune responses by priming T cells. Little is known about involvement of DC in multiple sclerosis (MS), where auto-aggressive T cells against myelin autoantigens are considered to contribute to inflammation and demyelination in the central nervous system. In this study, we compared phenotype and cytokine secretion of DC from patients with MS, other neurological diseases (OND) and healthy subjects. DC were generated from blood adherent mononuclear cells (MNC) by culture for 7 days with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). The yield and morphology of DC were similar in MS patients and controls. In both, the DC phenotype was that of immature myeloid lineage, comprising CD1a⁺ and CD11c⁺. The proportion of CD1a⁺ DC, being important for presentation of lipid antigens to T cells, was higher in MS patients compared to controls. The proportion of CD86⁺ DC, a co-stimulatory molecule that is assumed to promote Th2 differentiation, was low in MS. Low proportions of CD86⁺ DC were only observed in untreated MS patients but not in patients treated with IFN-b. Production of IL-10 and IL-12 p40 by DC did not differ in MS patients and controls. These findings indicate that alterations of functionally important surface molecules on DC are associated with MS.

Keywords

Dendritic cells multiple sclerosis CD1a CD86 cytokines

Get full access to this article

View all access options for this article.

References

Noseworthy JH. (1999) Progress in determining the causes and treatment of multiple sclerosis . Nature 399 (Suppl): A40-A47 .

Allegretta M , Nicklas JA , Sriram S , Albertini RJ. (1990) T cells responsive to myelin basic protein in patients with multiple sclerosis . Science 247: 718-721 .

Olsson T et al. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma . J Clin Invest 86: 981-985 .

Klein L , Klugmann M , Nave KA , Kyewski B. (2000) Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells . Nat Med 6: 56-61 .

Traugott U , Reinherz EL , Raine CS. (1983) Multiple sclerosis: Distribution of T cell subsets within chronic active lesions . Science 219: 308-310 .

Cannella B , Raine CS. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions . Ann Neurol 37: 424-435 .

Dittel BN , Visintin I , Merchant RM , Janeway Jr CA. (1999) Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis . J Immunol 163: 32-39 .

Irani DN , Griffin DE. (1996) Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection . J Immunol 156: 3850-3857 .

Banchereau J et al. (2000) Immunobiology of dendritic cells . Annu Rev Immunol 18: 767-811 .

10.

Turley SJ et al. (2000) Transport of peptide-MHC class II complexes in developing dendritic cells . Science 288: 522-527 .

11.

Kalinski P , Hilkens CM , Wierenga EA , Kapsenberg ML. (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal . Immunol Today 20: 561-567 .

12.

Vieira PL et al. (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction . J Immunol 164: 4507-4512 .

13.

Shamshiev A et al. (1999) Self glycolipids as T-cell autoantigens . Eur J Immunol 29: 1667-16675 .

14.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols . Ann Neurol 13: 227-231 .

15.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

16.

Ö zenci V et al. (2000) IL-12 ELISPOT assays to detect and enumerate IL-12 secreting cells . Cytokine 12: 1218-1224 .

17.

Rissoan MC et al. (1999) Reciprocal control of T helper cell and dendritic cell differentiation . Science 283: 1183-1186 .

18.

Porcelli SA et al. (1998) The CD1 family of lipid antigen-presenting molecules . Immunol Today 19: 362-368 .

19.

Battistini L , Fischer FR , Raine CS , Brosnan CF. (1996) CD1b is expressed in multiple sclerosis lesions . J Neuroimmunol 67: 145-151 .

20.

Buelens C et al. (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor . Eur J Immunol 27: 756-762 .

21.

Luft T et al. (1998) Type I IFNs enhance the terminal differentiation of dendritic cells . J Immunol 161: 1947-1953 .

22.

Bartholome EJ et al. (1999) Interferon-beta inhibits Th1 responses at the dendritic cell level: relevance to multiple sclerosis . Acta Neurol Belg 99: 44-52 .

23.

Takahashi K , Honeyman MC , Harrison LC. (1998) Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes . J Immunol 161: 2629-2635 .

24.

Kuchroo VK et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy . Cell 80: 707-718 .

25.

Genc K , Dona DL , Reder AT. (1997) Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy . J Clin Invest 99: 2664-2671 .

26.

Laman JD , Thompson EJ , Kappos L. (1998) Balancing the Th1/Th2 concept in multiple sclerosis . Immunol Today 19: 489-490 .

27.

Gao JX et al. (1999) CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection . Immunology 98: 159-170 .